1,441 to 1,447 of 1,447 Results
Jan 2, 2023 -
C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways
JPEG Image - 3.4 MB -
MD5: 2663c792229305b8584174eccbf93ebe
Figure S3. Effects of different concentrations of C5aRA on the expression of C5aR, IL-1β, IL-6, and TNF-α mRNA, determined using RT-PCR analysis. (A) C5aR; (B) IL-6; (C) IL-1β; and (D) TNF-α mRNA expression. Data represent the mean ± SEM of three independent experiments. * P < 0.... |
Jan 2, 2023 -
C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways
JPEG Image - 1.2 MB -
MD5: 7c6fd5205e5631af918798512bb58073
Schematic diagram of mechanism for anti-inflammatory action of C5aR antagonists (W54011). Complement and Toll-like receptors 4 (TLR4) are co-activated in response to lipopolysaccharide (LPS). During the activation of the complement cascade, C5 may be cleaved into its active produ... |
Jan 2, 2023 -
C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways
Plain Text - 3.8 KB -
MD5: 24501ebd59c9ae1e9855c1c58c36b01c
|
Jan 2, 2023 - Ciência & Saúde Coletiva
Batista, Joanna d'Arc Lyra; Alves, Rafael José Vargas; Cardoso, Taís Belladona; Moreno, Marcelo; Tiscoski, Katsuki Arima; Polanczyk, Carisi Anne, 2023, "Replication Data for: Efetividade do Trastuzumabe adjuvante em mulheres com câncer de mama HER-2+ no SUS", https://doi.org/10.48331/scielodata.KG1BRG, SciELO Data, V1, UNF:6:twusn2GcEJRPJRyvuyA/9g== [fileUNF]
Banco de dados do artigo. |
Jan 2, 2023 -
Replication Data for: Efetividade do Trastuzumabe adjuvante em mulheres com câncer de mama HER-2+ no SUS
Tabular Data - 12.8 KB - 24 Variables, 90 Observations - UNF:6:twusn2GcEJRPJRyvuyA/9g==
|
Jan 2, 2023 -
Replication Data for: Efetividade do Trastuzumabe adjuvante em mulheres com câncer de mama HER-2+ no SUS
MS Word - 13.1 KB -
MD5: bc729b0f2490d9521c05807f3bc2f5d6
|
Jan 2, 2023 -
Replication Data for: Efetividade do Trastuzumabe adjuvante em mulheres com câncer de mama HER-2+ no SUS
Plain Text - 1.3 KB -
MD5: 43eac63bc8565940dfd50890d31da777
Arquivo readme |